152 related articles for article (PubMed ID: 16737980)
1. Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study.
Manuel DG; Kwong K; Tanuseputro P; Lim J; Mustard CA; Anderson GM; Ardal S; Alter DA; Laupacis A
BMJ; 2006 Jun; 332(7555):1419. PubMed ID: 16737980
[TBL] [Abstract][Full Text] [Related]
2. The 2006 Canadian dyslipidemia guidelines will prevent more deaths while treating fewer people--but should they be further modified?
Manuel DG; Wilson S; Maaten S
Can J Cardiol; 2008 Aug; 24(8):617-20. PubMed ID: 18685741
[TBL] [Abstract][Full Text] [Related]
3. Comparing Guidelines for Statin Treatment in Canada and the United States.
Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
[TBL] [Abstract][Full Text] [Related]
4. Population health impact of statin treatment in Canada.
Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
[TBL] [Abstract][Full Text] [Related]
5. Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines.
Grover SA; Dorais M; Paradis G; Fodor JG; Frohlich JJ; McPherson R; Coupal L; Zowall H
CMAJ; 2000 Nov; 163(10):1263-9. PubMed ID: 11107461
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategies.
Nanchen D; Chiolero A; Cornuz J; Marques-Vidal PM; Firmann M; Mooser V; Paccaud F; Waeber G; Vollenweider P; Rodondi N
Am J Cardiol; 2009 Apr; 103(8):1089-95. PubMed ID: 19361595
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?
van Hout BA; Simoons ML
Eur Heart J; 2001 May; 22(9):751-61. PubMed ID: 11350107
[TBL] [Abstract][Full Text] [Related]
8. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based prediction of statin use with lipid-panel data from the National Health and Nutrition Examination Survey.
Gorevski E; Bian B; Kelton CM; Martin Boone JE; Guo JJ
Value Health; 2012 Jan; 15(1):32-8. PubMed ID: 22264969
[TBL] [Abstract][Full Text] [Related]
10. Achieving vascular risk factor targets: a survey of a London general practice.
Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
[TBL] [Abstract][Full Text] [Related]
11. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
12. Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study.
Stocks NP; Ryan P; McElroy H; Allan J
Med J Aust; 2004 Mar; 180(5):229-31. PubMed ID: 14984343
[TBL] [Abstract][Full Text] [Related]
13. Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience).
Elbarouni B; Banihashemi SB; Yan RT; Welsh RC; Kornder JM; Wong GC; Anderson FA; Spencer FA; Grondin FR; Goodman SG; Yan AT;
Am J Cardiol; 2012 May; 109(10):1418-24. PubMed ID: 22381155
[TBL] [Abstract][Full Text] [Related]
14. Expanding indications for statins in cerebral ischemia: a quantitative study.
Ovbiagele B; Kidwell CS; Saver JL
Arch Neurol; 2005 Jan; 62(1):67-72. PubMed ID: 15642851
[TBL] [Abstract][Full Text] [Related]
15. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
Mason CM
J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
[TBL] [Abstract][Full Text] [Related]
16. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
17. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
Idzior-Waluś B
Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
[TBL] [Abstract][Full Text] [Related]
19. Application of the 1998 Canadian cholesterol guidelines to a military population: health benefits and cost effectiveness of improved cholesterol management.
Spaans JN; Coyle D; Fodor G; Nair R; Vaillancourt R; Grover SA; Coupal L
Can J Cardiol; 2003 Jun; 19(7):790-6. PubMed ID: 12813612
[TBL] [Abstract][Full Text] [Related]
20. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
Manuel DG; Tanuseputro P; Mustard CA; Schultz SE; Anderson GM; Ardal S; Alter DA; Laupacis A
CMAJ; 2005 Apr; 172(8):1027-31. PubMed ID: 15824409
[No Abstract] [Full Text] [Related]
[Next] [New Search]
